We are launching this new research study to perform a retrospective analysis of clinical laboratory data from hundreds of ME / CFS patients. This study will gather and analyze the clinical laboratory tests and results ordered by ME / CFS specialists. We are hopeful that analyzing a large number of clinical records using robust statistical methods may reveal new insights.
Drs. David Kaufman and Bela Chheda (Center for Complex Diseases, CA) and Dr. Susan Levine (ME / CFS Clinician & Researcher, NY) will lead the first phase of this study using de-identified results from their patients. Later, we hope to bring on additional clinicians. Eventually, we plan to share the results with the whole ME / CFS medical and research communities.
We are very grateful to our newest partners who has stepped in to lead the data analysis pro-bono. We are grateful to Hany Zayed, PhD, Head of Data Sciences Solutions, Rigel Pharmaceuticals and OMF Foundation Board Member who will lead this project.
Donate your appreciated stock directly to OMF and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).